Collegium Pharmaceutical, Inc (COLL)

Current price: $23.80

These defaults work well for most companies. Only adjust them if you have a specific view on this business's risk profile or long-term growth prospects.

Discount Rate

Your required annual return on investmentTerminal Growth Rate

Long-run growth rate beyond projection period (≤ GDP growth)

Graham Number

√(22.5 × EPS × Book Value per Share)

$19.24

19% downside

Earnings Power Value

Normalized after-tax earnings ÷ required return (zero-growth)

$24.08

+1% upside

DCF Fair Value

Projected free cash flow discounted to present value + terminal value

$419.86

+1664% upside

P/E Fair Value

Earnings per share × target P/E multiple

$25.95

+9% upside

Target P/E Multiple

Long-run historical average: 32×

Valuation estimates are models, not investment advice. They are highly sensitive to the assumptions chosen and carry significant uncertainty. Past fundamentals do not guarantee future performance.